Ownership history in CITADEL ADVISORS LLC · 108 quarters on record
This page tracks every 13F SEC filing in which CITADEL ADVISORS LLC reported a position in DRXN DAILY S&P BIOTECH BULL (LABU). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 164,565 | -97,700 | -37.3% | 0.00% | $26.2M | $159.39 |
| 2025 Q4 | ADDED | 262,265 | +170,415 | +185.5% | 0.01% | $41.8M | $159.39 |
| 2025 Q3 | REDUCED | 91,850 | -125,180 | -57.7% | 0.00% | $8.6M | $93.13 |
| 2025 Q3 | REDUCED | 217,030 | -235,455 | -52.0% | 0.00% | $20.3M | $93.13 |
| 2025 Q3 | ADDED | 452,485 | +330,820 | +271.9% | 0.01% | $42.4M | $93.13 |
| 2025 Q2 | REDUCED | 121,665 | -155,385 | -56.1% | 0.00% | $6.9M | $56.55 |
| 2025 Q2 | ADDED | 277,050 | +42,290 | +18.0% | 0.00% | $15.8M | $56.55 |
| 2025 Q1 | ADDED | 234,760 | +56,010 | +31.3% | 0.00% | $14.3M | $60.35 |
| 2025 Q1 | ADDED | 178,750 | +58,250 | +48.3% | 0.00% | $10.9M | $60.35 |
| 2024 Q4 | REDUCED | 120,500 | -133,930 | -52.6% | 0.00% | $10.8M | $88.96 |
As of 2025 Q4 — sorted by position size